España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
BeiGene
BGNE
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$190.51
-4.05
-2.08%
At close: -
$190.51
0
0.00%
After Hours: Nov 22, 4:00 PM EDT
Get Report
Comment
BeiGene (BGNE) Forecast
News
Earnings
BeiGene (BGNE) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for BeiGene (NASDAQ:BGNE) Stock
BeiGene Stock (NASDAQ: BGNE)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, November 19, 2024
BeiGene Has Entered Into A Settlement Agreeme...
Benzinga Newsdesk
Thursday, November 14, 2024
BeiGene Intends To Change Name To BeOne Medic...
Benzinga Newsdesk
Wednesday, November 13, 2024
TD Cowen Maintains Buy on BeiGene, Raises Pri...
Benzinga Newsdesk
Tuesday, November 12, 2024
BeiGene shares are trading lower. The company...
Benzinga Newsdesk
BeiGene shares are trading higher after the c...
Benzinga Newsdesk
BeiGene Q3 2024 GAAP EPADS $(1.15) Beats $(1....
Benzinga Newsdesk
Thursday, November 07, 2024
Innovent Ditches Low-Value Stake Sale After Investor Outcry
The Bamboo Works
Tuesday, October 22, 2024
Expert Outlook: BeiGene Through The Eyes Of 4 Analysts
Benzinga Insights
JP Morgan Maintains Overweight on BeiGene, Ra...
Benzinga Newsdesk
Indaptus Therapeutics Announces Clinical Supp...
Benzinga Newsdesk
Monday, October 21, 2024
The Committee For Medicinal Products For Huma...
Benzinga Newsdesk
Thursday, October 17, 2024
Shares US-listed Chinese stocks are trading l...
Benzinga Newsdesk
Monday, October 14, 2024
Shares of US-listed Chinese stocks are tradin...
Benzinga Newsdesk
Tuesday, October 08, 2024
Shares of US-listed Chinese stocks are tradin...
Benzinga Newsdesk
Sunday, October 06, 2024
US Listed Chinese Stocks Dominate Another Week - Li Auto, JD.com Among Top 10 Large Cap Gainers Last Week (Sept 30-Oct 4): Are The Others In Your Portfolio?
Lekha Gupta
Friday, October 04, 2024
Shares of US-listed Chinese stocks are tradin...
Benzinga Newsdesk
Friday, September 27, 2024
BeiGene shares are trading higher after the c...
Benzinga Newsdesk
BeiGene's TEVIMBRA Gains FDA Panel Support fo...
Benzinga Newsdesk
Wednesday, September 25, 2024
FDA Casts Doubt On Use Of Merck, Bristol Myers' PD-1 Cancer Drugs For Certain Type Of Gastric Cancer Patients
Vandana Singh
Wednesday, September 18, 2024
Chinese Biotech BeiGene Labeled 'Unique Investment' As Analyst Confident In Lead Cancer Drug
Vandana Singh
What Analysts Are Saying About BeiGene Stock
Benzinga Insights
JMP Securities Initiates Coverage On BeiGene ...
Benzinga Newsdesk
Tuesday, September 17, 2024
BeiGene Says Israeli Ministry Of Health Appro...
Benzinga Newsdesk
Thursday, September 12, 2024
Oxford Industries Reports Weak Results, Joins Viper Energy And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Avi Kapoor
Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Friday, September 06, 2024
Innovent Bio hopes for plus-sized profits from obesity drug
The Bamboo Works
Monday, August 26, 2024
Top 2 Health Care Stocks That May Plunge In August
Avi Kapoor
BeiGene shares are trading higher after the c...
Benzinga Newsdesk
BeiGene Says FDA Granted Fast Track Designati...
Benzinga Newsdesk
Friday, August 23, 2024
Cancer Medicines From Merck, Bristol Myers And BeiGene In Question, As FDA Committee To Discuss Limiting PD-1 Drugs For Stomach Cancer
Vandana Singh
Tuesday, August 20, 2024
JP Morgan Maintains Overweight on BeiGene, Ra...
Benzinga Newsdesk
Thursday, August 08, 2024
Citigroup Maintains Buy on BeiGene, Raises Pr...
Benzinga Newsdesk
Wednesday, August 07, 2024
BeiGene shares are trading higher following b...
Benzinga Newsdesk
BeiGene Q2 2024 GAAP EPADS $(1.15) Beats $(2....
Benzinga Newsdesk
Tuesday, July 23, 2024
BeiGene Opens U.S. Biologics Manufacturing An...
Benzinga Newsdesk
Thursday, July 18, 2024
Beigene Has Appointed Aaron Rosenberg As Chie...
Benzinga Newsdesk
Tuesday, July 09, 2024
B of A Securities Maintains Neutral on BeiGen...
Benzinga Newsdesk
Sunday, June 30, 2024
Moderna And Walgreens Boots Alliance Were Among The 10 Biggest Large Cap Losers Last Week (June 23 - June 29): Are These In Your Portfolio?
Lekha Gupta
Monday, June 17, 2024
What's Going On With Small-Cap Cancer Focused Nurix Therapeutics On Monday?
Vandana Singh
Friday, June 14, 2024
BeiGene Says It Will Present New Data From SE...
Benzinga Newsdesk
Tuesday, May 28, 2024
BriaCell Therapeutics Announces Clinical Supp...
Benzinga Newsdesk
Sunday, May 26, 2024
Lululemon Athletica Was Among The Worst-Performing Stocks Last Week (May 19-May 26, 2024): Are These 10 Large-Cap Stock Losers In Your Portfolio?
Lekha Gupta
Friday, May 24, 2024
BeiGene Says BRUKINSA Data At American Societ...
Benzinga Newsdesk
Thursday, May 23, 2024
BeiGene's Aggressive Expansion Brings Revenue Jolt
The Bamboo Works
Tuesday, May 14, 2024
BeiGene To Highlight New Hematology Portfolio...
Benzinga Newsdesk
Thursday, May 09, 2024
TD Cowen Maintains Buy on BeiGene, Raises Pri...
Benzinga Newsdesk
Wednesday, May 08, 2024
BeiGene shares are trading higher after the c...
Benzinga Newsdesk
BeiGene Q1 2024 GAAP EPADS $(2.41) Beats $(2....
Benzinga Newsdesk
Sunday, April 28, 2024
Tracking Last Week's Top Performers: Are These 15 Large-Cap Stocks In Your Portfolio? (April 21-27, 2024)
Lekha Gupta
Friday, April 26, 2024
Hillhouse Boosts Longi Position After Robe, As It Pivots To Global Focus
The Bamboo Works
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
